Cambridge Investment Research Advisors’s Gentex GNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$221K Buy
+8,726
New +$206K ﹤0.01% 3732
2024
Q4
Sell
-8,364
Closed -$248K 3530
2024
Q3
$248K Buy
8,364
+17
+0.2% +$528 ﹤0.01% 2975
2024
Q2
$281K Buy
8,347
+26
+0.3% +$898 ﹤0.01% 2756
2024
Q1
$301K Sell
8,321
-1,245
-13% -$43.1K ﹤0.01% 2700
2023
Q4
$312K Buy
9,566
+70
+0.7% +$2.16K ﹤0.01% 2565
2023
Q3
$309K Sell
9,496
-68,731
-88% -$2.2M ﹤0.01% 2470
2023
Q2
$2.29M Sell
78,227
-5,961
-7% -$164K 0.01% 1090
2023
Q1
$2.36M Buy
84,188
+15,345
+22% +$432K 0.01% 1041
2022
Q4
$1.88M Buy
68,843
+2,255
+3% +$60.2K 0.01% 1109
2022
Q3
$1.59M Buy
66,588
+6,028
+10% +$165K 0.01% 1173
2022
Q2
$1.69M Sell
60,560
-7,916
-12% -$230K 0.01% 1128
2022
Q1
$2M Buy
68,476
+2,477
+4% +$77K 0.01% 1139
2021
Q4
$2.3M Sell
65,999
-3,209
-5% -$114K 0.01% 1057
2021
Q3
$2.28M Sell
69,208
-1,443
-2% -$46.6K 0.01% 1017
2021
Q2
$2.34M Buy
70,651
+12,695
+22% +$440K 0.01% 1023
2021
Q1
$2.07M Sell
57,956
-402
-0.7% -$14.3K 0.01% 990
2020
Q4
$1.98M Sell
58,358
-120
-0.2% -$3.7K 0.01% 927
2020
Q3
$1.51M Buy
58,478
+717
+1% +$19K 0.01% 957
2020
Q2
$1.49M Buy
57,761
+1,103
+2% +$27.6K 0.01% 906
2020
Q1
$1.26M Buy
56,658
+1,321
+2% +$36.7K 0.01% 862
2019
Q4
$1.6M Buy
55,337
+4,712
+9% +$133K 0.01% 894
2019
Q3
$1.39M Sell
50,625
-14,927
-23% -$394K 0.01% 902
2019
Q2
$1.61M Sell
65,552
-255
-0.4% -$5.78K 0.01% 803
2019
Q1
$1.36M Sell
65,807
-2,862
-4% -$59.8K 0.01% 884
2018
Q4
$1.39M Buy
68,669
+2,897
+4% +$60.7K 0.02% 786
2018
Q3
$1.41M Buy
65,772
+1,607
+3% +$37.2K 0.01% 831
2018
Q2
$1.48M Buy
64,165
+1,675
+3% +$39.7K 0.02% 774
2018
Q1
$1.44M Sell
62,490
-2,847
-4% -$64.8K 0.02% 754
2017
Q4
$1.37M Sell
65,337
-313
-0.5% -$6.23K 0.02% 756
2017
Q3
$1.3M Sell
65,650
-1,400
-2% -$25.5K 0.02% 714
2017
Q2
$1.27M Buy
67,050
+832
+1% +$16.2K 0.02% 693
2017
Q1
$1.41M Buy
66,218
+1,130
+2% +$23.7K 0.02% 588
2016
Q4
$1.28M Buy
65,088
+10,962
+20% +$200K 0.02% 574
2016
Q3
$950K Buy
54,126
+4,450
+9% +$76.9K 0.02% 707
2016
Q2
$768K Sell
49,676
-24,879
-33% -$395K 0.02% 737
2016
Q1
$1.17M Sell
74,555
-16,191
-18% -$236K 0.03% 509
2015
Q4
$1.45M Buy
90,746
+31,627
+53% +$511K 0.03% 437
2015
Q3
$916K Sell
59,119
-18,547
-24% -$295K 0.03% 512
2015
Q2
$1.27M Buy
77,666
+21,524
+38% +$376K 0.04% 430
2015
Q1
$1.03M Buy
56,142
+27,356
+95% +$483K 0.03% 494
2014
Q4
$512K Buy
+28,786
New +$478K 0.02% 764
2013
Q3
Sell
-20,986
Closed -$242K 1214
2013
Q2
$242K Buy
+20,986
New +$236K 0.01% 854

Other funds holding GNTX

Cambridge Investment Research Advisors's GNTX Position: Q2 2026 in Review

Cambridge Investment Research Advisors opened a new position in Gentex (GNTX) in Q2 2026: 8,726 shares worth $221K. The stake represents ﹤0.01% of the portfolio and ranks #3732 among its holdings. This is a return to the name: Cambridge Investment Research Advisors previously reported a position in GNTX as recently as Q3 2024.

Cambridge Investment Research Advisors first reported a position in GNTX in Q2 2013 and has held it in 42 quarters since. The position peaked at $2.36M in Q1 2023. 169 funds tracked by Wall St. Rank hold GNTX as of Q2 2026.

  • Cambridge Investment Research Advisors held 8,726 shares of Gentex worth $221K as of Q2 2026.
  • Gentex was a new Cambridge Investment Research Advisors position in Q2 2026.
  • Gentex made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3732 holding.
  • Cambridge Investment Research Advisors first reported a position in Gentex in Q2 2013 and has held it in 42 quarters since.
  • Cambridge Investment Research Advisors's Gentex position peaked at $2.36M in Q1 2023.
  • 169 funds tracked by Wall St. Rank held Gentex as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.